We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00971984
Recruitment Status : Completed
First Posted : September 4, 2009
Last Update Posted : September 1, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.

Condition or disease Intervention/treatment
Thalassemia Alpha Hemolytic Anemia Other: Medical records summary

Detailed Description:
Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized.

Study Design

Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
Study Start Date : October 2009
Primary Completion Date : April 2012
Study Completion Date : April 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia Thalassemia
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Alpha thalassemia patients
Patients diagnosed with alpha thalassemia mutations and anemia
Other: Medical records summary
Summary of Medical files and laboratory results.


Outcome Measures

Primary Outcome Measures :
  1. Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia [ Time Frame: One year ]
    Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 20 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A group of 50 children that underwent workup due to hemolytic anemia and were further diagnosis as suffering from clinical alpha thalassemia.
Criteria

Inclusion Criteria:

  • All the patients that were studied at the pediatric hematology unit ant the Ha'Emek Medical Center

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00971984


Locations
Israel
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
More Information

Responsible Party: Dr Koren Ariel, Head of Pediatric Hematology Unit and Pediatric Dpt B, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT00971984     History of Changes
Other Study ID Numbers: 0074-09-EMC
First Posted: September 4, 2009    Key Record Dates
Last Update Posted: September 1, 2015
Last Verified: August 2015

Additional relevant MeSH terms:
Thalassemia
Anemia, Hemolytic
alpha-Thalassemia
Anemia, Hemolytic, Congenital
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn